Outcome with Intensive Chemotherapy vs Hypomethylating Agent-Based Induction Strategies in Patients Older Than 70 Years with Newly Diagnosed, Favorable-Risk Acute Myeloid Leukemia

被引：0
|
作者：
Ball, Somedeb [1 ]
Jain, Akriti G. [1 ]
Al Ali, Najla [1 ]
Hayden, Alexander [2 ]
Swoboda, David M. [1 ]
Aguirre, Luis E. [1 ]
Sallman, David A. [1 ]
Padron, Eric [1 ]
Sweet, Kendra [1 ]
Lancet, Jeffrey E. [1 ]
Watts, Justin [3 ]
Pollyea, Daniel A. [2 ]
Komrokji, Rami S. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
[3] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2021年 / 21卷
关键词：
AML; elderly; 7+3; azacytidine; HMA; CR; overall survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-225
引用
收藏
页码：S293 / S293
页数：1
相关论文
共 50 条
  • [1] Intensive induction chemotherapy vs hypomethylating agent-based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia
    Lim, Matthew J.
    Agha, Aya
    Im, Annie
    Raptis, Anastasios
    Hou, Jing Z.
    Boyiadzis, Michael
    Sehgal, Alison R.
    Redner, Robert L.
    Dorritie, Kathleen
    Marks, Stanley S.
    Agha, Mounzer E.
    Lim, Seah H.
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (02) : 495 - 497
  • [2] Outcome with Intensive Chemotherapy Compared to Hypomethylating AgentBased Induction in Patients Aged 70 Years or Older with Newly Diagnosed Favorable Risk Acute Myeloid Leukemia
    Ball, Somedeb
    Jain, Akriti G.
    Aguirre, Luis E. E.
    Al Ali, Najla
    Bewersdorf, Jan Philipp
    Hayden, Alexander
    Siddon, Alexa J.
    Lykon, Jillian
    Madarang, Ellen
    Sallman, David A.
    Padron, Eric
    Sweet, Kendra
    Lancet, Jeffrey E.
    Watts, Justin M.
    Swoboda, David M.
    Pollyea, Daniel A.
    Zeidan, Amer M.
    Komrokji, Rami S.
    BLOOD, 2021, 138
  • [3] Intensive Chemotherapy in Patients Aged 70 Years or Older Newly Diagnosed With Acute Myeloid Leukemia
    Ross, Kelly
    Gillespie-Twardy, Amanda L.
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Redner, Robert L.
    Im, Annie
    Duggal, Shrina
    Ding, Fei
    Lin, Yan
    Boyiadzis, Michael
    ONCOLOGY RESEARCH, 2014, 22 (02) : 85 - 92
  • [4] Intensive Chemotherapy vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience
    Vachhani, Pankit
    Al Yacoub, Raed
    Miller, Austin
    Cronin, Tara
    Ontiveros, Evelena
    Thompson, James
    Griffiths, Elizabeth
    Wang, Eunice
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S288 - S289
  • [5] Intensive chemotherapy vs. hypomethylating agents in older adults with newly diagnosed high-risk acute myeloid leukemia: A single center experience
    Vachhani, Pankit
    Al Yacoub, Raed
    Miller, Austin
    Zhang, Fan
    Cronin, Tara L.
    Ontiveros, Evelena P.
    Thompson, James E.
    Griffiths, Elizabeth A.
    Wang, Eunice S.
    LEUKEMIA RESEARCH, 2018, 75 : 29 - 35
  • [6] Intensive Chemotherapy Vs. Hypomethylating Agents in Older Adults with Newly Diagnosed High-Risk Acute Myeloid Leukemia: A Single Center Experience
    Vachhani, Pankit
    Al Yacoub, Raed
    Miller, Austin
    Cronin, Tara
    Ontiveros, Evelena P.
    Thompson, James E.
    Griffiths, Elizabeth A.
    Wang, Eunice S.
    BLOOD, 2017, 130
  • [7] The outcome of intensive induction therapy in patients ≥70 years with acute myeloid leukemia
    Gupta, V.
    Xu, W.
    Keng, C.
    Alibhai, S. M. H.
    Brandwein, J.
    Schimmer, A.
    Schuh, A.
    Yee, K.
    Minden, M. D.
    LEUKEMIA, 2007, 21 (06) : 1321 - 1324
  • [8] The outcome of intensive induction therapy in patients ⩾70 years with acute myeloid leukemia
    V Gupta
    W Xu
    C Keng
    S M H Alibhai
    J Brandwein
    A Schimmer
    A Schuh
    K Yee
    M D Minden
    Leukemia, 2007, 21 : 1321 - 1324
  • [9] Risk Stratification of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive Chemotherapy
    Gardeney, Helene
    Diaz, Jose Miguel Torregrosa
    Basle, Caroline
    Cayssials, Emilie
    Bouyer, Sabrina
    Moya, Niels
    Gruchet, Cecile
    Sabirou, Florence
    Bobin, Arthur
    Levy, Anthony
    Nsiala, Laly
    Cailly, Laura
    Vonfeld, Mathilde
    Desmier, Deborah
    Leleu, Xavier
    Hernanz, Maria Pilar Gallego
    BLOOD, 2021, 138
  • [10] Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy
    Huggar, David
    Knoth, Russell L.
    Copher, Ronda
    Cao, Zhun
    Lipkin, Craig
    McBride, Ali
    LeBlanc, Thomas W.
    FUTURE ONCOLOGY, 2022, 18 (32) : 3609 - 3621
12345